Correlation Between Medicus Pharma and Meta Platforms

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medicus Pharma and Meta Platforms at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicus Pharma and Meta Platforms into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicus Pharma and Meta Platforms CDR, you can compare the effects of market volatilities on Medicus Pharma and Meta Platforms and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicus Pharma with a short position of Meta Platforms. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicus Pharma and Meta Platforms.

Diversification Opportunities for Medicus Pharma and Meta Platforms

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Medicus and Meta is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Medicus Pharma and Meta Platforms CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Meta Platforms CDR and Medicus Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicus Pharma are associated (or correlated) with Meta Platforms. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Meta Platforms CDR has no effect on the direction of Medicus Pharma i.e., Medicus Pharma and Meta Platforms go up and down completely randomly.

Pair Corralation between Medicus Pharma and Meta Platforms

Assuming the 90 days trading horizon Medicus Pharma is expected to generate 5.94 times more return on investment than Meta Platforms. However, Medicus Pharma is 5.94 times more volatile than Meta Platforms CDR. It trades about 0.21 of its potential returns per unit of risk. Meta Platforms CDR is currently generating about 0.37 per unit of risk. If you would invest  290.00  in Medicus Pharma on September 16, 2024 and sell it today you would earn a total of  105.00  from holding Medicus Pharma or generate 36.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Medicus Pharma  vs.  Meta Platforms CDR

 Performance 
       Timeline  
Medicus Pharma 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Medicus Pharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Medicus Pharma showed solid returns over the last few months and may actually be approaching a breakup point.
Meta Platforms CDR 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Meta Platforms CDR are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, Meta Platforms exhibited solid returns over the last few months and may actually be approaching a breakup point.

Medicus Pharma and Meta Platforms Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medicus Pharma and Meta Platforms

The main advantage of trading using opposite Medicus Pharma and Meta Platforms positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicus Pharma position performs unexpectedly, Meta Platforms can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Meta Platforms will offset losses from the drop in Meta Platforms' long position.
The idea behind Medicus Pharma and Meta Platforms CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios